Imgn, Immunogen, Inc.

Discussion in 'Investment Charts' started by ciao, Jul 30, 2017.

  1. ciao

    ciao Senior Investor

    Joined:
    Sep 2016
    Posts:
    769
    Likes Received:
    32
    [​IMG]
    Company Profile
    830 Winter Street
    Waltham, MA 02451
    United States
    781-895-0600
    http://www.immunogen.com

    Sector: Healthcare
    Industry: Biotechnology
    Full Time Employees: 308

    ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

    Statistics https://finance.yahoo.com/quote/IMGN/key-statistics?p=IMGN
    Holders https://finance.yahoo.com/quote/IMGN/holders?p=IMGN
     
  2. ciao

    ciao Senior Investor

    Joined:
    Sep 2016
    Posts:
    769
    Likes Received:
    32
  3. ciao

    ciao Senior Investor

    Joined:
    Sep 2016
    Posts:
    769
    Likes Received:
    32
    At close: July 28 4:00PM EDT 6.96+0.87 (+14.29%) A/H
    $7.11 +0.15 +2.16%

    Day's Range 6.29 - 7.15
    52 Week Range 1.51 - 8.04
    Volume 8,234,573
    Avg. Volume 2,921,425

    Resist. 8.04 - 9.39
    Sup. 6.45


    one of my latest scalp's stock... IMO next could be 8 but could test the sup still... DYOR + DD



     
  4. gowiththeflow

    gowiththeflow Senior Investor

    Joined:
    Jul 2017
    Posts:
    496
    Likes Received:
    8
    Very interesting - seems to be little resistance until $9 although the previous high of $8 (as you say) might be the next challenge?
     
  5. fireopal

    fireopal Senior Investor

    Joined:
    Jan 2017
    Posts:
    259
    Likes Received:
    5
  6. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,120
    Likes Received:
    19
    I agree - after a burst of life it seems to be headed downward just now. The classic pump and dump for short term traders?
     
  7. fireopal

    fireopal Senior Investor

    Joined:
    Jan 2017
    Posts:
    259
    Likes Received:
    5
    Nice little bounce from lower $5's support area but not enough vol to push it through 50 ma but trader interest might do it but not so sure about that either b/c looks like it might be awhile before anything significant comes from company.
     
  8. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,120
    Likes Received:
    19
    The shares need to stay above support levels for a few days before I would even consider buying - in that grey area at the moment when it looks like they are moving out of the down trend but could so easily slip back into it. Watch from the sidelines for now.

    Price $5.82 @ 7 Aug 2017
     
  9. fireopal

    fireopal Senior Investor

    Joined:
    Jan 2017
    Posts:
    259
    Likes Received:
    5
    ^^ am more of a swing/day trader so will play the chart and had a nice pop to $6.18 today before fading which is $1.01 per share for anyone that caught it @ $5.17 end of last week and that's not bad money!
     
  10. longtermbull

    longtermbull Administrator Staff Member

    Joined:
    Nov 2016
    Posts:
    1,120
    Likes Received:
    19
    Looks like the shares are heading for the next resistance level around $6.50. A safer buy when they go over but perhaps a buy now for the brave?

    Price $6.12 @ 16 Aug 2017
     
    Last edited: Aug 16, 2017

Share This Page